Home / Health / GLP-1 Drugs: Not a Magic Bullet, Experts Warn
GLP-1 Drugs: Not a Magic Bullet, Experts Warn
23 Feb
Summary
- GLP-1 medications like Ozempic are not a sole solution for weight loss.
- Stopping GLP-1s may lead to weight regain and muscle loss.
- A holistic approach with dietitians and exercise is recommended.
Australians are increasingly relying on GLP-1 medications like Ozempic and Mounjaro for weight loss, with over half a million currently using them monthly. However, experts like Professor Sarah Glastras warn against viewing these drugs as a complete solution. Emerging evidence suggests potential risks, including weight regain and loss of lean muscle and bone density once the medication is stopped. These effects can lead to decreased metabolic rate and increased risks of insulin resistance and heart disease.
Professor Glastras champions a more holistic approach to weight management, emphasizing the integration of GLP-1s with comprehensive care. This includes collaboration with dietitians, exercise physiologists, and counselors to provide structured and safe programs. Such a rounded strategy is crucial for tackling complex health challenges like obesity and heart disease, aiming for sustainable improvements for individuals and their families.
Recent research also supports a more accessible approach to physical activity, finding that 7,000 steps daily offers significant health benefits, including reduced risk of early death, dementia, and heart disease, comparable to 10,000 steps. This finding aims to provide a more realistic benchmark for daily movement, potentially encouraging broader engagement in physical well-being alongside medical treatments.
